PE20060379A1 - Derivados de 4-cicloalcoxibenzonitrilos como moduladores de androgenos - Google Patents
Derivados de 4-cicloalcoxibenzonitrilos como moduladores de androgenosInfo
- Publication number
- PE20060379A1 PE20060379A1 PE2005000789A PE2005000789A PE20060379A1 PE 20060379 A1 PE20060379 A1 PE 20060379A1 PE 2005000789 A PE2005000789 A PE 2005000789A PE 2005000789 A PE2005000789 A PE 2005000789A PE 20060379 A1 PE20060379 A1 PE 20060379A1
- Authority
- PE
- Peru
- Prior art keywords
- trifluoromethylbenzonitrile
- cyclohexil
- hept
- bicycle
- androgen
- Prior art date
Links
- 239000003098 androgen Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 abstract 2
- -1 2-ETHYL Chemical class 0.000 abstract 1
- AHHXZPGEBUMLBL-UHFFFAOYSA-N 4-cyclohexyloxy-2-(trifluoromethyl)benzonitrile Chemical compound C1=C(C#N)C(C(F)(F)F)=CC(OC2CCCCC2)=C1 AHHXZPGEBUMLBL-UHFFFAOYSA-N 0.000 abstract 1
- 201000004384 Alopecia Diseases 0.000 abstract 1
- 206010020112 Hirsutism Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 206010060862 Prostate cancer Diseases 0.000 abstract 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 abstract 1
- 102000001307 androgen receptors Human genes 0.000 abstract 1
- 108010080146 androgen receptors Proteins 0.000 abstract 1
- 201000002996 androgenic alopecia Diseases 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 210000002374 sebum Anatomy 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I, DONDE X1 ES HALOGENO, CIANO, HALOALCOXI, ALCOXI C1-C6, ENTRE OTROS; A ES CICLOPENTANO, 2-ETILCICLOHEXIL, BICICLO[2.2.1]HEPT-2-IL, 2-(S)-FENIL-(S)-CICLOHEXIL, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 4-(5-HIDROXI-5-METIL-BICICLO[2.2.1]HEPT-2-ILOXI)-2-TRIFLUOROMETILBENZONITRILO; 4-CICLOHEXILOXI-2-TRIFLUOROMETILBENZONITRILO; 4-(1-ALILCICLOHEXILOXI)-2-TRIFLUOROMETILBENZONITRILO; ENTRE OTROS. REFERIDA TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON ANTAGONISTAS DEL RECEPTOR DE ANDROGENOS, UTILES EN EL EXCESO DE SECRESION DE SEBO, ALOPECIA ANDROGENICA, CANCERES DEPENDIENTE DE HORMONAS TALES COMO CANCER DE PROSTATA E HIRSUTISMO
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58616004P | 2004-07-08 | 2004-07-08 | |
US59803304P | 2004-08-02 | 2004-08-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20060379A1 true PE20060379A1 (es) | 2006-05-27 |
Family
ID=35079243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2005000789A PE20060379A1 (es) | 2004-07-08 | 2005-07-06 | Derivados de 4-cicloalcoxibenzonitrilos como moduladores de androgenos |
Country Status (15)
Country | Link |
---|---|
US (2) | US7670613B2 (es) |
EP (1) | EP1781598A1 (es) |
JP (1) | JP4874965B2 (es) |
AR (1) | AR049965A1 (es) |
BR (1) | BRPI0513020A (es) |
CA (1) | CA2570047C (es) |
GT (1) | GT200500187A (es) |
MX (1) | MXPA06015169A (es) |
NL (1) | NL1029457C2 (es) |
PA (1) | PA8639001A1 (es) |
PE (1) | PE20060379A1 (es) |
SV (1) | SV2006002169A (es) |
TW (1) | TW200605876A (es) |
UY (1) | UY29008A1 (es) |
WO (1) | WO2006006065A1 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2554696C (en) | 2004-02-13 | 2009-06-30 | Warner-Lambert Company Llc | Androgen receptor modulators |
US7507860B2 (en) | 2004-04-13 | 2009-03-24 | Pfizer Inc. | Androgen modulators |
JP2007533726A (ja) * | 2004-04-22 | 2007-11-22 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | アンドロゲンモジュレーター |
MXPA06015169A (es) | 2004-07-08 | 2007-08-21 | Warner Lambert Co | Moduladores de androgenos. |
WO2006018732A1 (en) * | 2004-08-18 | 2006-02-23 | Warner-Lambert Company Llc | Androgen modulators |
TW200724139A (en) | 2005-05-05 | 2007-07-01 | Warner Lambert Co | Androgen modulators |
US8359450B2 (en) * | 2009-02-13 | 2013-01-22 | Opnet Technologies, Inc. | Memory utilization analysis |
CN104736569A (zh) | 2012-01-12 | 2015-06-24 | 耶鲁大学 | 通过e3泛素连接酶增强靶蛋白质及其他多肽降解的化合物和方法 |
GB201311888D0 (en) | 2013-07-03 | 2013-08-14 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
GB201311891D0 (en) | 2013-07-03 | 2013-08-14 | Glaxosmithkline Ip Dev Ltd | Novel compound |
US10071164B2 (en) | 2014-08-11 | 2018-09-11 | Yale University | Estrogen-related receptor alpha based protac compounds and associated methods of use |
KR102564925B1 (ko) * | 2015-01-20 | 2023-08-07 | 아비나스 오퍼레이션스, 인코포레이티드 | 안드로겐 수용체의 표적화된 분해를 위한 화합물 및 방법 |
US20170327469A1 (en) | 2015-01-20 | 2017-11-16 | Arvinas, Inc. | Compounds and methods for the targeted degradation of androgen receptor |
BR112018008918A8 (pt) | 2015-11-02 | 2019-02-26 | Univ Yale | compostos de quimera proteólise dirigida e métodos para preparação e uso dos mesmos |
AU2017295038B2 (en) | 2016-07-15 | 2022-09-22 | Centre Hospitalier Sainte Anne Paris | 5-hydroxytryptamine 1B receptor-stimulating agent for skin and/or hair repair |
AU2017341723B2 (en) | 2016-10-11 | 2021-12-16 | Arvinas Operations, Inc. | Compounds and methods for the targeted degradation of androgen receptor |
WO2021127443A1 (en) | 2019-12-19 | 2021-06-24 | Arvinas Operations, Inc. | Compounds and methods for the targeted degradation of androgen receptor |
Family Cites Families (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6124343A (en) | 1919-01-27 | 2000-09-26 | Rhone-Poulenc Rorer Limited | Substituted phenyl compounds with a substituent having a thienyl ring |
US3535365A (en) | 1967-11-29 | 1970-10-20 | Merck & Co Inc | Preparation of 2,6-dichloro-4-methoxy-benzonitrile |
SU469247A3 (ru) | 1972-01-14 | 1975-04-30 | Майлз Лабораториз Инк (Фирма) | Способ получени производных хромона |
US4029493A (en) | 1973-02-23 | 1977-06-14 | Mobil Oil Corporation | Substituted phenoxybenzonitriles as herbicides |
FR2397387A1 (fr) | 1976-04-27 | 1979-02-09 | Serobiologiques Lab Sa | 4,4'-bis-formyl-polyhalo-diphenoxyalcanes, procede de preparation et application a la synthese de 4,4'-dicyano-polyhalo-diphenoxyalcanes |
US4234595A (en) | 1977-07-13 | 1980-11-18 | Mead Johnson & Company | 3-Indolyl-tertiary butylaminopropanols |
EP0002309B1 (en) | 1977-10-12 | 1982-12-01 | Imperial Chemical Industries Plc | Acylanilides, process for their manufacture and pharmaceutical and veterinary compositions containing them |
US4567201A (en) | 1981-11-25 | 1986-01-28 | Takeda Chemical Industries, Ltd. | Diphenoxypropane derivatives and compositions of antiasthmatic and antiinflammatory agents thereof |
GB8504093D0 (en) | 1985-02-18 | 1985-03-20 | Ici Plc | Alkene alkyne/cycloalkylene derivatives |
DE3372965D1 (en) | 1982-07-23 | 1987-09-17 | Ici Plc | Amide derivatives |
DE3382646D1 (de) | 1982-08-26 | 1993-01-28 | Merck Patent Gmbh | Cyclohexanderivate und ihre verwendung als komponenten fluessigkristalliner-dielektrika. |
JPS59144747A (ja) | 1983-02-04 | 1984-08-18 | Chisso Corp | 2−クロロ−4−アルキルオキシベンゾニトリル化合物 |
US4536321A (en) | 1983-02-18 | 1985-08-20 | Chisso Corporation | Fluorobenzene derivatives and liquid crystal compositions containing the same |
JPS63227502A (ja) | 1987-03-17 | 1988-09-21 | Sds Biotech Kk | 防菌防カビ剤 |
US4992433A (en) | 1987-11-23 | 1991-02-12 | Janssen Pharmaceutica N.V. | Novel pyridazinamine derivatives |
US4925590A (en) | 1988-03-10 | 1990-05-15 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Derivatives of 4-cyano-2,3-difluorophenol |
DE3825170A1 (de) | 1988-07-23 | 1990-01-25 | Hoechst Ag | Substituierte 5-(4-(4,5-dihydro-2-oxazolyl)-phenoxyalkylenoxyalkyl)-isoxazole, verfahren sowie 5-(phenoxyalkylenoxyalkyl)-isoxazole als zwischenprodukte zu ihrer herstellung und ihre verwendung zur bekaempfung von krankheiten, die durch infektion mit viren hervorgerufen wurden |
DE4017019A1 (de) | 1990-05-26 | 1991-11-28 | Hoechst Ag | Verwendung von substituierten ss-hydroxyethylaminen als potente hemmstoffe der exoenzyme von pilzen |
JPH04124183A (ja) | 1990-09-14 | 1992-04-24 | Mitsubishi Rayon Co Ltd | 光学活性パントラクトン誘導体 |
JP3088777B2 (ja) | 1991-03-27 | 2000-09-18 | 富士薬品工業株式会社 | 新規光学分割剤及びそれを用いる光学活性アミンの製造方法 |
JP3151929B2 (ja) | 1992-05-15 | 2001-04-03 | 大日本インキ化学工業株式会社 | フルオロシクロヘキセン誘導体 |
DE4217928A1 (de) | 1992-05-30 | 1993-12-02 | Hoechst Ag | Neue Mischungen aus Herbiziden und Antidots, neue (Hetero-)Aryloxy-Verbindungen, Verfahren zu deren Herstellung, diese enthaltenden Mittel und deren Verwendung |
JPH0641038A (ja) | 1992-07-17 | 1994-02-15 | Mitsubishi Kasei Corp | カルボン酸誘導体 |
US5455274A (en) | 1992-12-09 | 1995-10-03 | Ciba-Geigy Corporation | Hydroxyamidine derivatives |
US5316755A (en) | 1993-02-02 | 1994-05-31 | Sterling Winthrop Inc. | Compositions of iodophenoxy alkanes and iodophenyl ethers for visualization of the gastrointestinal tract |
GB2278054A (en) | 1993-05-18 | 1994-11-23 | Zeneca Ltd | Compounds for the treatment of urinary incontinence |
TW262553B (es) | 1994-03-17 | 1995-11-11 | Hitachi Seisakusyo Kk | |
EP0756497A1 (en) | 1994-04-21 | 1997-02-05 | Nycomed Imaging As | X-ray contrast compositions containing pharmaceutically acceptable clays |
JPH07309850A (ja) | 1994-05-16 | 1995-11-28 | Canon Inc | 光学活性化合物、それを含有する液晶組成物、それを有する液晶素子及びそれらを用いた表示方法、表示装置 |
CA2150326A1 (en) | 1994-05-27 | 1995-11-28 | Kimihiro Murakami | Azolyl methyl phenyl derivatives having aromatase inhibitory activity |
ATE210657T1 (de) | 1994-10-14 | 2001-12-15 | Merck Patent Gmbh | Zns wirksames (r)-(-)-2-(5-(4-fluorophenyl)-3- pyridylmethylaminomethyl)chroman |
JP3802581B2 (ja) * | 1995-03-01 | 2006-07-26 | 富山化学工業株式会社 | 新規なビフェニル誘導体またはその塩およびそれらを含有する抗炎症剤 |
JPH0953018A (ja) * | 1995-06-09 | 1997-02-25 | Mitsubishi Chem Corp | フタロシアニン誘導体及び該誘導体を使用した光学記録媒体 |
US5656651A (en) * | 1995-06-16 | 1997-08-12 | Biophysica Inc. | Androgenic directed compositions |
DE19534209A1 (de) | 1995-09-15 | 1997-03-20 | Jenapharm Gmbh | Hormonales Mittel zur Behandlung der Haut |
ES2127106B1 (es) | 1996-03-21 | 1999-11-16 | Menarini Lab | Derivados benzopiranicos con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de los mismos. |
US5847166A (en) * | 1996-10-10 | 1998-12-08 | Massachusetts Institute Of Technology | Synthesis of aryl ethers |
US6071957A (en) * | 1996-11-27 | 2000-06-06 | The University Of Tennessee Research Corporation | Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer |
CA2278190A1 (en) | 1997-02-04 | 1998-08-06 | Hong-Suk Suh | 3-amino-1,2-benzoisoxazole derivatives, process for preparation, and use thereof |
US6013668A (en) | 1997-08-13 | 2000-01-11 | Bristol-Myers Squibb Company | Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl) amino]methyl]amino]benzonitrile |
US6297239B1 (en) | 1997-10-08 | 2001-10-02 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
US6184249B1 (en) | 1998-12-18 | 2001-02-06 | Biophysica, Inc. | Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes |
CZ2002711A3 (cs) * | 1999-08-27 | 2003-11-12 | Ligand Pharmaceuticals Incorporated | Modulátory androgenních receptorů, způsoby jejich výroby a způsoby jejich použití |
WO2001056989A2 (en) | 2000-02-01 | 2001-08-09 | Cor Therapeutics, Inc. | Inhibitors of factor xa |
KR100849981B1 (ko) | 2000-07-13 | 2008-08-01 | 메르크 파텐트 게엠베하 | 키랄 화합물 i |
PT1401801E (pt) * | 2000-08-24 | 2007-02-28 | Univ Tennessee Res Foundation | Modulares selectivos de receptor de androgénio e métodos para a sua utilização |
OA12372A (en) | 2000-08-31 | 2006-04-17 | Pfizer | Phenoxybenzylamine derivatives as selective seotonin re-uptake inhibitors. |
AU2002211805A1 (en) | 2000-09-06 | 2002-03-22 | Emisphere Technologies, Inc. | Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents |
CA2424964C (en) * | 2000-10-06 | 2007-12-04 | Tanabe Seiyaku Co., Ltd. | Nitrogen-containing 5-membered ring compound |
WO2002057215A2 (en) | 2001-01-16 | 2002-07-25 | Theravance, Inc. | Sodium channel modulators |
KR20030070150A (ko) | 2001-01-31 | 2003-08-27 | 화이자 프로덕츠 인크. | Pde4 이소자임 억제제로서 유용한 에테르 유도체 |
DE60219292T2 (de) | 2001-04-10 | 2008-04-10 | Pfizer Inc. | Pyrazolderivate zur behandlung von hiv |
AR035700A1 (es) | 2001-05-08 | 2004-06-23 | Astrazeneca Ab | Derivados de arilheteroalquilamina, composicion farmaceutica, usos de estos derivados para la fabricacion de medicamentos, metodos de tratamiento, y proceso para la preparacion de estos derivados |
RS69704A (en) | 2002-02-07 | 2006-12-15 | Gtx Inc. | Treating bening prostate hyperplasia with sarms |
TW200302722A (en) | 2002-02-13 | 2003-08-16 | Astrazeneca Ab | Therapeutic agents |
CN1633287A (zh) | 2002-02-15 | 2005-06-29 | 恩多研究公司 | 联苯衍生物及其作为抗雄激素试剂的应用 |
IL163742A0 (en) | 2002-02-28 | 2005-12-18 | Univ Tennessee Res Foundation | Irreversible selective androgen receptor modulators and methods of use thereof |
US7268152B2 (en) | 2002-03-26 | 2007-09-11 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
US6875438B2 (en) | 2002-04-27 | 2005-04-05 | Aventis Pharma Deutschland Gmbh | Preparations for topical administration of substances having antiandrogenic activity |
DE10218963A1 (de) | 2002-04-27 | 2003-11-20 | Aventis Pharma Gmbh | Zubereitungen zur topischen Applikation von antiandrogen wirksamen Substanzen |
US6951884B2 (en) | 2002-06-12 | 2005-10-04 | Hoffmann-La Roche Inc. | Fluorobenzamides and uses thereof |
US7582230B2 (en) | 2002-08-14 | 2009-09-01 | Ciba Specialty Chemicals Corporation | Liquid crystal display and colour filter with improved transparency for green light |
WO2004018386A2 (en) | 2002-08-26 | 2004-03-04 | Merck & Co., Inc. | Acetophenone potentiators of metabotropic glutamate receptors |
PL374732A1 (en) * | 2002-09-19 | 2005-10-31 | Abbott Laboratories | Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
BRPI0410561A (pt) | 2003-06-18 | 2006-06-20 | Pfizer Prod Inc | lactamas de piperazinileteroarilóxi-n-arill e de piperazinilarilóxi |
FI20030958A0 (fi) | 2003-06-27 | 2003-06-27 | Orion Corp | Uusia yhdisteitä |
EP1673357A2 (en) | 2003-08-08 | 2006-06-28 | Vertex Pharmaceuticals Incorporated | Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
GB0324551D0 (en) | 2003-10-21 | 2003-11-26 | Karobio Ab | Novel compounds |
JP2007521328A (ja) | 2003-11-20 | 2007-08-02 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | アンドロゲン受容体モジュレーター |
CA2554696C (en) | 2004-02-13 | 2009-06-30 | Warner-Lambert Company Llc | Androgen receptor modulators |
US7507860B2 (en) | 2004-04-13 | 2009-03-24 | Pfizer Inc. | Androgen modulators |
JP2007533726A (ja) | 2004-04-22 | 2007-11-22 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | アンドロゲンモジュレーター |
PL1747198T3 (pl) | 2004-05-07 | 2008-11-28 | Janssen Pharmaceutica Nv | Pochodne adamantylopirolidyn-2-onu jako inhibitory 11ß-dehydrogenazy hydroksysteroidowej |
MXPA06015169A (es) | 2004-07-08 | 2007-08-21 | Warner Lambert Co | Moduladores de androgenos. |
WO2006018732A1 (en) | 2004-08-18 | 2006-02-23 | Warner-Lambert Company Llc | Androgen modulators |
KR20070049238A (ko) | 2004-08-31 | 2007-05-10 | 워너-램버트 캄파니 엘엘씨 | 안드로겐 조절제 |
ATE419848T1 (de) | 2004-10-29 | 2009-01-15 | Lilly Co Eli | Cycloalkyl-lactam-derivate als inhibitoren von 11-beta-hydroxysteroiddehydrogenase 1 |
TW200724139A (en) | 2005-05-05 | 2007-07-01 | Warner Lambert Co | Androgen modulators |
-
2005
- 2005-06-27 MX MXPA06015169A patent/MXPA06015169A/es active IP Right Grant
- 2005-06-27 BR BRPI0513020-4A patent/BRPI0513020A/pt not_active IP Right Cessation
- 2005-06-27 EP EP05757544A patent/EP1781598A1/en not_active Withdrawn
- 2005-06-27 WO PCT/IB2005/001999 patent/WO2006006065A1/en active Application Filing
- 2005-06-27 CA CA2570047A patent/CA2570047C/en not_active Expired - Fee Related
- 2005-06-27 JP JP2007519910A patent/JP4874965B2/ja not_active Expired - Fee Related
- 2005-07-04 GT GT200500187A patent/GT200500187A/es unknown
- 2005-07-05 US US11/175,097 patent/US7670613B2/en not_active Expired - Fee Related
- 2005-07-06 AR ARP050102808A patent/AR049965A1/es unknown
- 2005-07-06 PE PE2005000789A patent/PE20060379A1/es not_active Application Discontinuation
- 2005-07-07 UY UY29008A patent/UY29008A1/es not_active Application Discontinuation
- 2005-07-07 NL NL1029457A patent/NL1029457C2/nl not_active IP Right Cessation
- 2005-07-07 TW TW094123000A patent/TW200605876A/zh unknown
- 2005-07-08 SV SV2005002169A patent/SV2006002169A/es not_active Application Discontinuation
- 2005-07-08 PA PA20058639001A patent/PA8639001A1/es unknown
-
2009
- 2009-11-05 US US12/546,103 patent/US20100048517A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
UY29008A1 (es) | 2006-03-31 |
CA2570047A1 (en) | 2006-01-19 |
SV2006002169A (es) | 2006-02-15 |
GT200500187A (es) | 2006-02-17 |
JP4874965B2 (ja) | 2012-02-15 |
US20100048517A1 (en) | 2010-02-25 |
US7670613B2 (en) | 2010-03-02 |
TW200605876A (en) | 2006-02-16 |
CA2570047C (en) | 2010-09-28 |
MXPA06015169A (es) | 2007-08-21 |
EP1781598A1 (en) | 2007-05-09 |
PA8639001A1 (es) | 2006-06-02 |
NL1029457A1 (nl) | 2006-01-10 |
US20060009427A1 (en) | 2006-01-12 |
JP2008505880A (ja) | 2008-02-28 |
WO2006006065A1 (en) | 2006-01-19 |
BRPI0513020A (pt) | 2008-04-22 |
AR049965A1 (es) | 2006-09-20 |
NL1029457C2 (nl) | 2006-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20060379A1 (es) | Derivados de 4-cicloalcoxibenzonitrilos como moduladores de androgenos | |
PE20070427A1 (es) | Compuestos derivados de benzimidazoles sustituidos como inhibidores de tirosina quinasas | |
PE20090816A1 (es) | Derivados de pirrolopirimidinona como agentes ligandos de los receptores p2x3 | |
PE20221336A1 (es) | Compuestos triciclicos sustituidos | |
PE20140858A1 (es) | Derivados de piperidina como inhibidores de renina | |
PE20070093A1 (es) | Derivados dihidrobenzofuranos como moduladores del receptor 5-ht2c | |
PE20090678A1 (es) | Combinaciones de compuestos inhibidores de fosfoinositida 3-quinasa y agentes quimioterapeuticos y los metodos de uso | |
PE20090546A1 (es) | Derivados de imidazol como antagonistas de los receptores de quimioquina ccr-2, ccr-3 y ccr-5 | |
HRP20150437T1 (en) | Diarylhydantoin compounds as androgen receptor antagonists for treatment of cancer | |
BR0009320A (pt) | Dibenzopiranos como antagonistas do receptor glicocorticóide para o tratamento da diabete | |
UY26482A1 (es) | Bifenil sulfonamidas como antagonistas de receptores de angiotensina endotelina duales | |
PE20091335A1 (es) | Derivados de ftalazinona | |
PE20081362A1 (es) | DERIVADOS MORFOLINO PIRIMIDINA COMO INHIBIDORES DE mTOR QUINASA Y PI3K | |
PE20121050A1 (es) | Compuestos de n-(1-(4-(1h-pirazol-5-il)ftalazin-1-il)piperidin-4-il)-benzamida sustituidos como antagonistas de la trayectoria hedgehog | |
PE20010854A1 (es) | USO DE DERIVADOS DE PIRIMIDINA 4 SUSTITUIDOS COMO ANTAGONISTAS DE LOS RECEPTORES DE GLUTAMATO mGluR1 | |
PE20061439A1 (es) | DERIVADOS DE 2-AMIDO-6-AMINO-8-OXO-PURINA COMO MODULADORES DEL RECEPTOR Toll (TLR) | |
PE20091724A1 (es) | Derivados de indol como moduladores del receptor nicotinico de acetilcolina alfa 7 | |
PE20060401A1 (es) | Derivados de n-(2-bencil)-2-fenil-butanamidas y propanamidas como moduladores del receptor de androgeno | |
BRPI0412314A (pt) | derivados de pirimidina-2,4-diona como antagonistas de receptor de hormÈnio liberador de gonadotropina | |
PE20121282A1 (es) | Antagonistas de espiro-oxindol de mdm2 | |
ATE366721T1 (de) | Indolinderivate als progesteron antagonisten | |
TW200800975A (en) | New compounds 2 | |
PE20081346A1 (es) | Derivados de espiroindolinona como antagonistas de mdm2 | |
PE20060084A1 (es) | Hidrocloruro de [4-(5-(aminometil-2-fluoro-fenil)-piperidin-1-il]-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos | |
UY28150A1 (es) | Agentes terapeuticos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |